Sensitive and frequent identification of high avidity neo-epitope specific CD8+ T cells in immunotherapy-naive ovarian cancer

被引:118
作者
Bobisse, Sara [1 ]
Genolet, Raphael [1 ]
Roberti, Annalisa [2 ]
Tanyi, Janos L. [2 ]
Racle, Julien [1 ,3 ]
Stevenson, Brian J. [3 ]
Iseli, Christian [3 ]
Michel, Alexandra [1 ]
Le Bitoux, Marie-Aude [1 ]
Guillaume, Philippe [1 ]
Schmidt, Julien [1 ]
Bianchi, Valentina [1 ]
Dangaj, Denarda [1 ]
Fenwick, Craig [4 ]
Derre, Laurent [5 ]
Xenarios, Ioannis [3 ]
Michielin, Olivier [1 ,3 ]
Romero, Pedro [1 ]
Monos, Dimitri S. [3 ,6 ]
Zoete, Vincent [1 ,3 ]
Gfeller, David [1 ]
Kandalaft, Lana E. [1 ,2 ]
Coukos, George [1 ]
Harari, Alexandre [1 ]
机构
[1] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Univ Hosp, Dept Oncol, CH-1066 Lausanne, Switzerland
[2] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA
[3] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland
[4] Lausanne Univ Hosp, Dept Med, Div Immunol & Allergy, CH-1066 Lausanne, Switzerland
[5] Lausanne Univ Hosp, Urol Res Unit, CH-1011 Lausanne, Switzerland
[6] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Immunogenet Lab, Philadelphia, PA 19104 USA
来源
NATURE COMMUNICATIONS | 2018年 / 9卷
关键词
TUMOR-INFILTRATING LYMPHOCYTES; MULTIPLE SEQUENCE ALIGNMENT; CHIMERIC ANTIGEN RECEPTOR; METASTATIC MELANOMA; CTLA-4; BLOCKADE; PATIENT; NEOANTIGENS; ASSOCIATION; EXPRESSION; REACTIVITY;
D O I
10.1038/s41467-018-03301-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Immunotherapy directed against private tumor neo-antigens derived from non-synonymous somatic mutations is a promising strategy of personalized cancer immunotherapy. However, feasibility in low mutational load tumor types remains unknown. Comprehensive and deep analysis of circulating and tumor-infiltrating lymphocytes (TILs) for neo-epitope specific CD8(+) T cells has allowed prompt identification of oligoclonal and polyfunctional such cells from most immunotherapy-naive patients with advanced epithelial ovarian cancer studied. Neo-epitope recognition is discordant between circulating T cells and TILs, and is more likely to be found among TILs, which display higher functional avidity and unique TCRs with higher predicted affinity than their blood counterparts. Our results imply that identification of neoepitope specific CD8(+) T cells is achievable even in tumors with relatively low number of somatic mutations, and neo-epitope validation in TILs extends opportunities for mutanomebased personalized immunotherapies to such tumors.
引用
收藏
页数:10
相关论文
共 54 条
  • [31] Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
    Rajasagi, Mohini
    Shukla, Sachet A.
    Fritsch, Edward F.
    Keskin, Derin B.
    DeLuca, David
    Carmona, Ellese
    Zhang, Wandi
    Sougnez, Carrie
    Cibulskis, Kristian
    Sidney, John
    Stevenson, Kristen
    Ritz, Jerome
    Neuberg, Donna
    Brusic, Vladimir
    Gabriel, Stacey
    Lander, Eric S.
    Getz, Gad
    Hacohen, Nir
    Wu, Catherine J.
    [J]. BLOOD, 2014, 124 (03) : 453 - 462
  • [32] Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
    Rizvi, Naiyer A.
    Hellmann, Matthew D.
    Snyder, Alexandra
    Kvistborg, Pia
    Makarov, Vladimir
    Havel, Jonathan J.
    Lee, William
    Yuan, Jianda
    Wong, Phillip
    Ho, Teresa S.
    Miller, Martin L.
    Rekhtman, Natasha
    Moreira, Andre L.
    Ibrahim, Fawzia
    Bruggeman, Cameron
    Gasmi, Billel
    Zappasodi, Roberta
    Maeda, Yuka
    Sander, Chris
    Garon, Edward B.
    Merghoub, Taha
    Wolchok, Jedd D.
    Schumacher, Ton N.
    Chan, Timothy A.
    [J]. SCIENCE, 2015, 348 (6230) : 124 - 128
  • [33] Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
    Robbins, Paul F.
    Lu, Yong-Chen
    El-Gamil, Mona
    Li, Yong F.
    Gross, Colin
    Gartner, Jared
    Lin, Jimmy C.
    Teer, Jamie K.
    Cliften, Paul
    Tycksen, Eric
    Samuels, Yardena
    Rosenberg, Steven A.
    [J]. NATURE MEDICINE, 2013, 19 (06) : 747 - +
  • [34] A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
    Robbins, PF
    ElGamil, M
    Li, YF
    Kawakami, Y
    Loftus, D
    Appella, E
    Rosenberg, SA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) : 1185 - 1192
  • [35] T-cell target antigens across major gynecologic cancers
    Rodriguez-Garcia, Alba
    Minutolo, Nicholas G.
    Robinson, John M.
    Powell, Daniel J.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 (03) : 426 - 435
  • [36] Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
    Rooney, Michael S.
    Shukla, Sachet A.
    Wu, Catherine J.
    Getz, Gad
    Hacohen, Nir
    [J]. CELL, 2015, 160 (1-2) : 48 - 61
  • [37] The RCSB Protein Data Bank: redesigned web site and web services
    Rose, Peter W.
    Beran, Bojan
    Bi, Chunxiao
    Bluhm, Wolfgang F.
    Dimitropoulos, Dimitris
    Goodsell, David S.
    Prlic, Andreas
    Quesada, Martha
    Quinn, Gregory B.
    Westbrook, John D.
    Young, Jasmine
    Yukich, Benjamin
    Zardecki, Christine
    Berman, Helen M.
    Bourne, Philip E.
    [J]. NUCLEIC ACIDS RESEARCH, 2011, 39 : D392 - D401
  • [38] Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
    Rosenberg, Steven A.
    Yang, James C.
    Sherry, Richard M.
    Kammula, Udai S.
    Hughes, Marybeth S.
    Phan, Giao Q.
    Citrin, Deborah E.
    Restifo, Nicholas P.
    Robbins, Paul F.
    Wunderlich, John R.
    Morton, Kathleen E.
    Laurencot, Carolyn M.
    Steinberg, Seth M.
    White, Donald E.
    Dudley, Mark E.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (13) : 4550 - 4557
  • [39] Systematic evaluation of multiple immune markers reveals prognostic factors in ovarian cancer
    Santoiemma, Phillip P.
    Reyes, Carolina
    Wang, Li-Ping
    McLane, Mike W.
    Feldman, Michael D.
    Tanyi, Janos L.
    Powell, Daniel J., Jr.
    [J]. GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 120 - 127
  • [40] Schlienger K, 2003, CLIN CANCER RES, V9, P1517